Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by ledrogon Sep 20, 2019 5:26pm

215 Views

Post# 30150050

RE:RE:Fear

Did you see how AMRN traded just before they announced their results? I'd be worried if the PPS was soaring on heavy volume just before results, encouraging the sheep to buy high....now I see this as tree shaking to get the herd to sell low....here's AMRN's Chart just before it exploded:

User image

It looks like we have another week of trading at least before we get a thumbs up or a thumbs down....if your confident the trial is going to fail, then borrow all you can and dump them on a short play....but don't blame anyone else if you get creamed by successful news, life is a gamble.

Bullboard Posts

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle